Sequential Therapy versus Triple Therapy for the First Line Treatment of Helicobacter pylori in Korea: A Nationwide Randomized Trial

Uloženo v:
Podrobná bibliografie
Název: Sequential Therapy versus Triple Therapy for the First Line Treatment of Helicobacter pylori in Korea: A Nationwide Randomized Trial
Autoři: Hyun Joo Song, Su Jin Hong, Sang Wook Kim, Jin Il Kim, Jie Hyun Kim, Joon Sung Kim, Gwang Ho Baik, Ki Nam Shim, Ji Hyun Kim, Byung-Wook Kim
Přispěvatelé: College of Medicine, Dept. of Internal Medicine, Joon Sung Kim, Byung-Wook Kim, Su Jin Hong, Jin Il Kim, Ki-Nam Shim, Jie-Hyun Kim, Gwang Ho Baik, Sang Wook Kim, Hyun Joo Song, Ji Hyun Kim, Kim, Ji Hyun
Zdroj: Gut Liver
Gut and Liver, Vol 10, Iss 4, Pp 556-561 (2016)
Informace o vydavateli: The Editorial Office of Gut and Liver, 2016.
Rok vydání: 2016
Témata: Adult, Male, RC799-869, Drug Administration Schedule, Helicobacter Infections, Medication Adherence, 03 medical and health sciences, 0302 clinical medicine, Anti-Bacterial Agents/administration & dosage, Drug Therapy, Proton Pump Inhibitors/administration & dosage, Clarithromycin, Metronidazole, Republic of Korea, Humans, Aged, drug resistance, Helicobacter pylori, Disease eradication, Amoxicillin, Proton Pump Inhibitors, Diseases of the digestive system. Gastroenterology, Middle Aged, Helicobacter Infections/drug therapy, Clarithromycin/administration & dosage, Anti-Bacterial Agents, Intention to Treat Analysis, 3. Good health, Treatment Outcome, Drug resistance, Amoxicillin/administration & dosage, Combination, Metronidazole/administration & dosage, helicobacter pylori, disease eradication, Original Article, Drug Therapy, Combination, Female, Helicobacter pylori/drug effects
Popis: Eradication of Helicobacter pylori infection with standard triple therapy (TT) has declined primarily because of increased antibiotic resistance. Sequential therapy (ST) has been suggested as an alternative to TT for the first-line treatment of H. pylori. The purpose of this study was to compare the efficacy of ST with TT.This was a multicenter, randomized open-label trial performed at nine centers in Korea. Patients with H. pylori infection were randomly assigned to receive either 7 day TT or 10 day ST. Eradication rates, drug compliance, and adverse events were compared among the two regimens.A total of 601 patients were enrolled between March 2011 and September 2014. The intention-to-treat eradication rates were 70.8% for TT and 82.4% for ST (p=0.001). The corresponding per protocol eradication rates were 76.9% and 88.8% for TT and ST, respectively (p=0.000). There were no statistically significant differences between the two regimens with respect to drug compliance and adverse events.ST achieved better eradication rates than TT as a first-line therapy for H. pylori eradication in Korea.
Druh dokumentu: Article
Other literature type
Jazyk: English
ISSN: 2005-1212
1976-2283
DOI: 10.5009/gnl15470
Přístupová URL adresa: http://www.gutnliver.org/journal/download_pdf.php?doi=10.5009/gnl15470
https://pubmed.ncbi.nlm.nih.gov/27114421
https://doaj.org/article/8320b0aeae59445b9be24f5d0d1307f3
https://pure.ewha.ac.kr/en/publications/sequential-therapy-versus-triple-therapy-for-the-first-line-treat
https://yonsei.pure.elsevier.com/en/publications/sequential-therapy-versus-triple-therapy-for-the-first-line-treat
https://dspace.ewha.ac.kr/handle/2015.oak/231748
http://europepmc.org/articles/PMC4933415
https://www.gutnliver.org/journal/view.html?uid=913
https://www.ncbi.nlm.nih.gov/pubmed/27114421
Rights: CC BY NC
CC BY NC ND
Přístupové číslo: edsair.doi.dedup.....c4783e6814c4a906194595332c431bc7
Databáze: OpenAIRE
Popis
Abstrakt:Eradication of Helicobacter pylori infection with standard triple therapy (TT) has declined primarily because of increased antibiotic resistance. Sequential therapy (ST) has been suggested as an alternative to TT for the first-line treatment of H. pylori. The purpose of this study was to compare the efficacy of ST with TT.This was a multicenter, randomized open-label trial performed at nine centers in Korea. Patients with H. pylori infection were randomly assigned to receive either 7 day TT or 10 day ST. Eradication rates, drug compliance, and adverse events were compared among the two regimens.A total of 601 patients were enrolled between March 2011 and September 2014. The intention-to-treat eradication rates were 70.8% for TT and 82.4% for ST (p=0.001). The corresponding per protocol eradication rates were 76.9% and 88.8% for TT and ST, respectively (p=0.000). There were no statistically significant differences between the two regimens with respect to drug compliance and adverse events.ST achieved better eradication rates than TT as a first-line therapy for H. pylori eradication in Korea.
ISSN:20051212
19762283
DOI:10.5009/gnl15470